Alamar Biosciences, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Alamar Biosciences, Inc. (ALMR) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 9.09 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-11
- Alamar Biosciences, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 9.09M shares, a 79.72% decline year-over-year.
- Alamar Biosciences, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 51.50M shares, a 15.24% increase year-over-year.
- Alamar Biosciences, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 44.83M shares.
- Alamar Biosciences, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 44.69M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month |
|---|---|---|
| 2026-06-30 | 9.09M shares 10-Q · filed 2026-08-11 | 9.09M shares 10-Q · filed 2026-08-11 |
| 2026-03-31 | 51.50M shares 10-Q · filed 2026-05-08 | |
| 2025-06-30 | 44.83M shares 10-Q · filed 2026-08-11 | 44.83M shares 10-Q · filed 2026-08-11 |
| 2025-03-31 | 44.69M shares 10-Q · filed 2026-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |